Study predicts strong global growth for drug industry

07/2/2013 | PharmaTimes (U.K.)

With the peak of generic competition for patented drugs in the past, the pharmaceutical industry is poised for sustained growth that will reach a total value of $895 billion in the next five years, according to the annual World Preview by the research firm Evaluate. The report predicts that, by 2018, biological products will constitute half of the sales of the top 100 products worldwide, Novartis will be the world's largest pharmaceutical firm, AbbVie's tumor necrosis inhibitor Humira will be the biggest-selling drug product, and anticoagulant therapies will become the fastest-growing sector, increasing more than 11% in five years.

View Full Article in:

PharmaTimes (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory FDA
Cardinal Health
Columbus, OH
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA